Substance Details ADB-BUTINACA - Revision history

ISZCindy643869 at 19:18, 28 May 2026

2026-05-28T19:18:46Z

ReinaldoTew087 at 06:54, 27 May 2026

2026-05-27T06:54:56Z

ISZCindy643869 at 03:38, 27 May 2026

2026-05-27T03:38:25Z

BillyTrego at 03:25, 27 May 2026

2026-05-27T03:25:05Z

MaximoYeb5954 at 07:05, 26 May 2026

2026-05-26T07:05:06Z

EarnestineEarp at 07:10, 25 May 2026

2026-05-25T07:10:14Z

RebekahRea71555: Created page with "Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selecte..."

2026-05-25T07:07:16Z

Created page with "Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selecte..."

New page

Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound Fig. 2. Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender Cannabinoidsrc 4f Adb blog post and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite. Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden Cannabinoidsrc 4f Adb blog post headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging . Data availability The intensity is plotted against the retention time for both chromatograms, demonstrating the Cannabinoidsrc 4f Adb [https://cannabinoidsrc4f-adb.com/ Cannabinoidsrc 4f Adb blog post] post presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom

← Older revision		Revision as of 19:18, 28 May 2026
Line 1:		Line 1:
−	~~The current study indicates~~ that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have ~~similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in~~ a ~~similar fashion~~. ~~Much of the in vivo [https://cannabinoidsrc4f~~-~~adb.com/ 5CLADBA] testing~~ of ~~the synthetic cannabinoid compounds have been pre~~-~~clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some~~ of ~~the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al.~~, ~~2016)~~, ~~and a compound from the present study~~, ~~5F-MDMB-PINACA~~, ~~was found to activate midbrain dopamine neurons~~, ~~but not serotonin neurons (Asaoka et al., 2016<br><br>Figure 1~~. ~~<br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-~~THC~~) found in marijuana~~, ~~but have different chemical structures unrelated to Δ9-THC~~, ~~different metabolism~~, ~~and often greater toxicity~~ (~~Fantegrossi et al., 2014~~)~~. Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg~~, ~~30-min pretreatment). 5F~~-~~MDMB-PINACA~~ (~~also known as 5F-ADB, 5F-ADB-PINACA~~)~~, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA,~~ and ~~AMB-FUBINACA (also known as FUB~~-~~AMB~~, ~~MMB-FUBINACA) were tested for in vivo cannabinoid-like effects~~ to ~~assess their abuse liabilit<br><br>In-vitro metabolism studies are generally used to complement these~~ data ~~using perfused organs, tissue or cell cultures and microsomal preparations amongst~~ which ~~pooled human liver microsomes (HLM) have been frequently used~~ to ~~elucidate metabolism~~ of ~~SCBs [12,13,14,15,16~~<br><br> Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>~~The % peak area abundance ratio~~ of ~~metabolites detected~~ in ~~the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of~~ drug ~~and intake frequency), time from last drug intake and metabolic stability~~. ~~This indicated that~~ the ~~phase I metabolism~~ of 4F-MDMB-BINACA ~~are unlikely to be affected significantly by polydrug intake~~. ~~Oxidative defluorination with subsequent butanoic acid formation~~ (~~B17~~) ~~metabolite~~, the ~~second major metabolite after monohydroxylation~~ in the C. ~~Ester hydrolysis with dehydrogenation formed in~~-~~vivo in~~ this study was ~~also reported among other indazole carboxamide type SCBs with tert~~-~~leucine methyl ester moieties such as 5F~~-~~MDMB-PINACA~~ and ~~MDMB-4en-PINACA [39~~, ~~40]~~. ~~Similar to the in~~-~~vivo findings~~, 4F-~~MDMB~~-~~BINACA ester hydrolysis (B22) was the major metabolite for both HepG2~~ and ~~HLM models, consistent with the known hydrolytic activity of CES reported~~<br><br><br>§ (3) ~~of the Hungarian act of Forensic Experts~~ (~~2016~~.~~XXIX)~~, ~~the data of the reported case can be utilized freely for scientific and educational purposes~~ without ~~special ethical permission. These results indicate that the simultaneous intoxication~~ of ~~SCRA~~ and ~~ethanol directly and exclusively caused the death~~ of ~~the two victims~~. ~~The victims did not have any significant diseases that could have contributed to~~ the ~~outcome. Very limited data are available in the scientific literature about the possible~~ effects ~~of the combined consumption~~ of SCRAs and ~~ethanol~~. ~~Several case reports describe that the presence of a little~~ ng/mL (0.37–4.1) ~~of SCRAs and a high—but not lethal—concentration of ethanol (~~1.~~45–2~~.7 g/L~~) directly and exclusively contributed to the death~~ of the ~~victim [24–27] (Table 2)~~. The ~~fact that~~ 4F-MDMB-BINACA ~~was~~ not ~~detected in postmortem urine samples is partly explained~~ by the ~~high rate of hepatic~~ metabolism of ~~SCRAs [11, 14, 22], but also suggests that the victims consumed~~ 4F-MDMB-BINACA ~~shortly before their death~~<br><br><br>~~As synthetic cannabinoid receptor agonists~~ (~~SCRA~~) ~~are gaining popularity globally~~, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the ~~onset~~ of ~~his symptoms~~. ~~Metabolic acidosis~~ (~~1/3~~, ~~0/7~~) and ~~respiratory acidosis (1/3,~~ 0/7), ~~All 10 patients recovered with supportive care~~, ~~including intubation~~ and ~~ventilation for one case~~. ~~In 3 cases ADB~~-~~BUTINACA was the only substance detected~~, ~~while in seven other substances~~ of ~~misuse were also detected including other SCRA~~, ~~opioids~~, ~~benzodiazepines cocaine~~ and ~~pregabali~~<br><br>~~Figure 1.~~ <br>~~Each training session lasted a maximum~~ of ~~10 min~~, and the ~~rats could earn up to 20 food pellets~~. ~~Thirty minutes prior to~~ the ~~training sessions~~, ~~rats received an injection~~ of ~~either vehicle or Δ9~~-~~THC~~ and were ~~subsequently placed in~~ the ~~behavior~~-~~testing chambers~~, ~~where food~~ (45-~~mg food pellets~~; ~~Bio~~-~~Serve~~, ~~Frenchtown~~, ~~NJ) was available~~ as a ~~reinforcer for every ten responses~~ (~~FR10~~) on a ~~designated injection appropriate lever~~. ~~A houselight was centered over the hopper close~~ to ~~the ceiling~~ and ~~was illuminated only when the levers were active~~. ~~Each dose range included~~ doses that ~~were without effect to those producing at least 50% depression compared to vehicle control~~. ~~Twenty~~-~~four male Sprague~~-~~Dawley rats were obtained from Envigo~~ (~~Houston~~, TX). ~~Male ND4 Swiss–Webster mice were obtained from Envigo~~ (~~Houston, TX~~) at ~~approximately 8 weeks of age~~ and ~~maintained in the University of North Texas Health Science Center~~ (~~UNTHSC~~) ~~animal facility for two weeks prior to testin~~	+	A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours<br><br>Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>This might be due to the low activity of numerous metabolizing enzymes resulting in lower drug biotransformation . HepG2 model detected the major ester hydrolysis metabolite of 4F-MDMB-BINACA in abundance but the rest of the metabolites were found in a small amount. Elegans and HLM models detected all of the in-vivo metabolites (100%), whilst HepG2 cells detected 7 out of the 8 in-vivo metabolites (87.5%). Hence, structural elucidation could not be confirmed unless a reference standard is made availabl<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 hop over to these guys μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br><br>Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol.<br>Fig. 2. <br>4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed and processed using TraceFinder software based on the identification criteria of mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex-mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature, and 150 µL of purified water was added. High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated in both positive and negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC-C18 analytical column (2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA).<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f-adb.com/ hop over to these guys] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect

← Older revision		Revision as of 06:54, 27 May 2026
Line 1:		Line 1:
−	The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ ~~cannabinoidsrc4f-adb.com~~] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>~~Although there were reports on the metabolism of 4F~~-~~MDMB~~-~~BINACA using~~ in-~~vivo~~ and ~~various in-vitro models~~, ~~studies~~ were ~~either conducted using small~~ in-~~vivo sample size such as 1 to 4 samples [5~~, ~~29] or in closed environments such as forensic psychiatric wards and prisons~~ . ~~The hepatic cell line HepG2 is often used~~ as ~~an initial screen as it is known to produce high reproducibility results with relatively stable enzyme concentration~~, ~~although they are limited by the low~~-~~level expression of several metabolizing enzymes~~, ~~including the cytochrome P450~~ (~~CYP~~) ~~class of proteins [17, 18].~~ In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16~~]. Since most SCBs are found extensively in metabolized forms~~ in urine, ~~the identification~~ of ~~metabolites is of vital importance for forensic~~ and ~~clinical toxicologists. Identifying SCB~~ intake and ~~its correlating specific adverse effects require rapid elucidation~~ of ~~these SCBs~~. ~~The proliferation of~~ SCBs ~~has become a global challenge~~ as ~~new compounds are rapidly introduced into~~ the ~~illegal drug market to evade existing drug law~~<br><br><br>~~Test 2 was performed everyday for 5 days after consecutive administration~~ of the ~~substances, including negative~~ (~~vehicle~~) and ~~positive (methamphetamine) controls~~. ~~After~~ the ~~last administration,~~ the ~~first trial was performed~~. ~~Morris water maze test was performed~~ to ~~evaluate~~ the ~~changes~~ of ~~learning~~ and ~~memory function through administration~~ of ~~the test substances~~. ~~Generally, neurotoxicity~~ of a ~~substance is evaluated by animal behavioral aspects, i~~.e. ~~functional observation battery (FOB~~) ~~tests~~ (~~O’Callaghan et al., 2014~~). ~~Our results suggest~~ that ~~JWH~~-~~081 and JWH~~-~~210 may cannabinoidsrc4f-adb.com be neurotoxic substances through changing neuronal cell damages, especially~~ in the ~~core shell part~~ of ~~nucleus accumbens.<br>About Powder JWH~~-2<br><br>~~Legal status~~ <br>~~JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound~~ that ~~meets stringent requirements~~. ~~Researchers often require compounds~~ that ~~are consistent and dependable, and this product delivers on both fronts. Whether used in small~~-~~scale experiments or larger research projects,~~ the ~~compound maintains its integrity under recommended storage conditions~~. ~~This ensures ease of handling~~ and ~~precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity~~, ~~consistency~~, and ~~accuracy, making it suitable~~ for ~~controlled experimental environments~~. ~~This study~~ was ~~supported by a grant (13181MFDS654) of~~ the ~~National Institute~~ of ~~Food and Drug Safety Evaluation~~, ~~Ministry of Food~~ and ~~Drug Safety, Republic of Kore~~<br><br>4. ~~Drugs~~ <br>~~Short-onset, short-acting compounds have~~ a ~~greater abuse liability~~, and ~~long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs~~. ~~The duration of action of the synthetic cannabinoids tested using~~ the ~~8-h protocol have varied widely~~, ~~with some producing a duration~~ of ~~action no longer than 1 h, others producing a duration of action between 1–2 h,~~ and ~~others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compounds. All of the compounds tested~~ in the ~~present study depressed locomotor activity as is typical for other synthetic cannabinoids~~ (~~see review by Wiley et al.~~, ~~2017~~)~~. Average horizontal activity counts/10 min~~ as a ~~function of time~~ (~~10 min bins~~) ~~and dose~~. ~~Depressant effects of 1.33 mg/kg were observed within 10 min following administration~~ and ~~peak depressant effects~~ were ~~observed between 0–30 min~~.~~<br>Michael B Gat<br><br><br>These synthetic cannabinoids act cannabinoidsrc4f-adb~~.~~com directly at cannabinoid CB1 and CB2 receptors as does Δ9~~-~~tetrahydrocannabinol (Δ9~~-~~THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity~~ (~~Fantegrossi et al.~~, ~~2014~~). ~~Discriminative stimulus effects~~ were ~~tested in rats trained to discriminate Δ9-tetrahydrocannabinol~~ (~~3 mg/kg~~, ~~30-min pretreatment~~)~~. 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA,~~ and ~~AMB-FUBINACA~~ (~~also known as FUB-AMB, MMB-FUBINACA~~) ~~were tested~~ for ~~in vivo cannabinoid-like effects~~ to ~~assess their abuse liabilit~~	+	The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ 5CLADBA] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br>Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br>In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16<br><br> Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>The % peak area abundance ratio of metabolites detected in the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stability. This indicated that the phase I metabolism of 4F-MDMB-BINACA are unlikely to be affected significantly by polydrug intake. Oxidative defluorination with subsequent butanoic acid formation (B17) metabolite, the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in-vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA and MDMB-4en-PINACA [39, 40]. Similar to the in-vivo findings, 4F-MDMB-BINACA ester hydrolysis (B22) was the major metabolite for both HepG2 and HLM models, consistent with the known hydrolytic activity of CES reported<br><br><br>§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>Figure 1. <br>Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin

← Older revision		Revision as of 03:38, 27 May 2026
Line 1:		Line 1:
−	~~Acute kidney damage~~ and ~~even kidney failure have been reported following use~~ of ~~synthetic cannabinoids (Davidson~~, ~~et al.~~, ~~2017)~~. ~~One recent study has looked at other mechanisms~~ of ~~action~~ in ~~some~~ of the ~~older~~ synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid ~~receptors more strongly than Δ9~~-~~THC or whether these "super~~-~~strength" cannabinoids produce~~ effects ~~at other receptors~~. ~~A major cause of concern~~ is that some of the ~~more recently seen~~ synthetic cannabinoids ~~are more likely to produce extremely toxic effects~~ than ~~the older synthetics~~ (~~Tai and Fantegrossi~~, ~~2017<br><br>The findings produce an apparent paradox~~, ~~since CPP~~ and ~~self-administration predict with high reliability the likelihood that~~ a compound ~~will be abused by humans~~, ~~and cannabinoids are well~~-~~known~~ to ~~produce active drug-seeking in human~~<br><br><br>~~Thirty minutes prior to~~ the ~~training sessions, rats received an injection~~ of ~~either vehicle or Δ9~~-~~THC~~ and ~~were subsequently placed~~ in ~~the behavior~~-~~testing chambers~~, ~~where food (45~~-~~mg food pellets; Bio-Serve~~, ~~Frenchtown, NJ) was available~~ as ~~a reinforcer for every ten responses (FR10) on a designated injection appropriate lever~~. ~~A houselight was centered over the hopper close~~ to the ~~ceiling and was illuminated only when~~ the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (~~Houston, TX~~)~~. cannabinoidsrc4f-adb.com~~ [~~https://cannabinoidsrc4f-adb~~.~~com/ cannabinoidsrc4f~~-~~adb.com site] Male ND4 Swiss–Webster mice were obtained from Envigo~~ (~~Houston, TX~~) ~~at approximately 8 weeks~~ of ~~age and maintained~~ in the ~~University~~ of ~~North Texas Health Science Center (UNTHSC) animal facility~~ for ~~two weeks prior~~ to ~~testin~~<br><br><br>~~§ (3)~~ of the ~~Hungarian act of Forensic Experts~~ (~~2016.XXIX~~)~~, the data of the reported case can be utilized freely for scientific~~ and ~~educational purposes without special ethical permission~~. ~~These results indicate that~~ the ~~simultaneous intoxication of SCRA and ethanol directly and exclusively caused~~ the ~~death of the two victims~~. ~~The victims did not have any significant diseases that could have contributed~~ to the ~~outcome. Very limited data are available in the scientific literature about the possible effects~~ of the ~~combined consumption of SCRAs and ethanol~~. ~~Several case reports describe that the presence~~ of a ~~little ng/mL (0~~.~~37–4~~.1) ~~of SCRAs and a high—but not lethal—concentration of ethanol~~ (1.~~45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2~~). ~~The fact~~ that 4F-~~MDMB~~-~~BINACA was not detected~~ in ~~postmortem urine samples is partly explained by~~ the ~~high rate~~ of ~~hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F~~-~~MDMB-BINACA shortly before their death~~<br><br>~~The % peak area abundance ratio of metabolites detected~~ in the ~~urine samples are often affected~~ by ~~numerous factors such as drug intake behaviour~~ (~~intake route~~, ~~amount~~ of ~~drug~~ and ~~intake frequency)~~, ~~time from last drug intake and metabolic stabilit~~<br><br>4. Drugs <br>~~The purpose of the present study was to assess the abuse liability of 5F~~-~~MDMB-PINACA~~, ~~MDMB~~-~~CHIMICA~~, ~~MDMB~~-~~FUBINACA, ADB~~-~~FUBINACA,~~ and ~~AMB-FUBINACA~~. The ~~findings produce an apparent paradox~~, ~~since CPP and self-administration predict~~ with ~~high reliability the likelihood that~~ a ~~compound will be abused by humans~~, and cannabinoids ~~are well-known to produce active drug-seeking in humans~~. ~~Drug discrimination is a well-known animal model~~ of the ~~subjective effects of drugs and correlates well with abuse liability~~ (~~Young 2009; Horton~~ et al. ~~2013~~). ~~Assessment~~ of ~~abuse liability is based on several factors, including chemical structure, pharmacological mechanism~~ of ~~action,~~ and ~~finally, subjective and reinforcing behavioral~~ effects ~~(FDA, 2010; Swedberg, 2013)~~.<br>Michael B Gat<br><br><br>These synthetic cannabinoids act cannabinoidsrc4f-adb.com ~~site~~ directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patient.<br>Data availabili	+	The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Although there were reports on the metabolism of 4F-MDMB-BINACA using in-vivo and various in-vitro models, studies were either conducted using small in-vivo sample size such as 1 to 4 samples [5, 29] or in closed environments such as forensic psychiatric wards and prisons . The hepatic cell line HepG2 is often used as an initial screen as it is known to produce high reproducibility results with relatively stable enzyme concentration, although they are limited by the low-level expression of several metabolizing enzymes, including the cytochrome P450 (CYP) class of proteins [17, 18]. In-vitro metabolism studies are generally used to complement these data using perfused organs, tissue or cell cultures and microsomal preparations amongst which pooled human liver microsomes (HLM) have been frequently used to elucidate metabolism of SCBs [12,13,14,15,16]. Since most SCBs are found extensively in metabolized forms in urine, the identification of metabolites is of vital importance for forensic and clinical toxicologists. Identifying SCB intake and its correlating specific adverse effects require rapid elucidation of these SCBs. The proliferation of SCBs has become a global challenge as new compounds are rapidly introduced into the illegal drug market to evade existing drug law<br><br><br>Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may cannabinoidsrc4f-adb.com be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.<br>About Powder JWH-2<br><br>Legal status <br>JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br>4. Drugs <br>Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compounds. All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were observed between 0–30 min.<br>Michael B Gat<br><br><br>These synthetic cannabinoids act cannabinoidsrc4f-adb.com directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit

← Older revision		Revision as of 03:25, 27 May 2026
Line 1:		Line 1:
−	~~Metabolic Profile~~ of ~~Synthetic Cannabinoids 5F-PB-22~~, ~~PB-22~~, ~~XLR-11 and UR-144 by Cunninghamella elegans <br>The % peak area abundance ratio~~ of ~~metabolites detected~~ in the ~~urine samples~~ are ~~often affected by numerous factors such as drug intake behaviour~~ (~~intake route~~, ~~amount of drug and intake frequency~~)~~, time from last drug intake and metabolic stability~~. ~~This indicated that~~ the ~~phase I metabolism~~ of 4F-~~MDMB~~-~~BINACA~~ are ~~unlikely~~ to ~~be affected significantly by polydrug intake. Oxidative defluorination with subsequent butanoic acid formation~~ (B17) metabolite, the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in-vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA and ~~MDMB-4en-PINACA [39~~, ~~40]. Similar to the in-vivo~~ findings, 4F-~~MDMB-BINACA ester hydrolysis (B22) was~~ the ~~major metabolite for both HepG2~~ and ~~HLM models, consistent with the~~ known ~~hydrolytic activity of CES reported~~<br><br><br>~~In summary~~, ~~JWH~~-~~210 Chemical Powder stands out~~ as a ~~high-quality research compound designed~~ for ~~professionals who demand accuracy, consistency,~~ and ~~reliability~~. ~~This commitment~~ to [https://cannabinoidsrc4f-adb.com/ ~~visit this website link~~] ~~quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging~~, ~~every stage~~ of the ~~process is monitored~~ to ~~ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.~~<br>~~Key Features and Specifications to Evaluate~~ <br>In case of ~~cannabis or Δ9-tetrahydrocannabinol, there~~ are ~~many visit this website link previous studies regarding with their dependence potential~~ and ~~neurotoxicity~~ (~~Cororan, et al~~.~~, 1974; Harris, et al~~.~~, 1974; Leite~~ and ~~Culini, 1974; Hutcheson, et al~~.~~, 1998~~). ~~After administering test substances once every other day for 10 days, brain~~ samples of ~~mice were collected~~, ~~especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day~~, ~~and~~ the ~~first trial was performed 2 h after~~ the last ~~administration.~~<br>~~How to Choose Powder JWH-210~~ <br>~~This dual-use nature underscores~~ the ~~importance~~ of ~~responsible sourcing and strict adherence to legal frameworks. Forensic labs~~, ~~public health researchers~~, and ~~customs officials use authentic samples like JWH~~-~~210 to distinguish between legal and illegal compounds in seized materials~~. ~~For those seeking a dependable compound for analytical purposes~~, ~~JWH~~-~~210 Chemical Powder provides~~ a ~~trusted and effective solution. With its carefully controlled production process, stable composition~~, and ~~secure packaging, it remains a valuable resource for laboratory~~-~~based research~~.~~<br>Is JWH~~-~~210 Legal? <br>A total~~ of ~~2 and 3 methamphetamine treated mice fell from~~ the ~~spinning rod 30 min~~ and ~~2 hr after the administration~~, ~~respectively. After the first injection~~, ~~6 mice~~ of ~~the positive control group~~ (~~methamphetamine~~, ~~5 mg/kg~~, ~~i.p.~~) ~~showed loss of traction, of which 4 showed tremor~~. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance<br><br>~~Figure 1.~~ <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>~~After the incubation~~, ~~mixture was centrifuged (18~~,~~000 x g~~, ~~20 °C) for 5 min~~ and 0.~~5 μL of the supernatant was directly injected to the chromatographic system. In the next step~~, ~~ammonium formate as salting agent was added to the mixture and incubated in a thermomixer~~ (~~20 °C~~, ~~1200 rpm~~) ~~for 15 min. After vortex~~-~~mixing~~, the ~~mixture~~ was ~~allowed~~ to ~~stand visit this website link~~ at ~~room temperature for 5 min. MS/MS experiments were performed in MRM (multiple reaction monitoring) mode with~~ an ~~isolation window of 0~~.~~4 m/z. The MS measurement was performed in positive ion mode (except for some acidic compounds such as barbiturates~~<br><br>~~Fig. 2. <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L~~, ~~respectively). Forensic autopsy of both victims was performed four days after~~ the ~~time~~ of ~~death following the Recommendation No.R (99)3 of the Council of Europe on medico~~-~~legal autopsies. Elegans demonstrated the ability to form all~~ of ~~the in~~-~~vivo metabolites and has the potential to be used as a complementary model to predict~~ and ~~characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs~~. ~~Thus, identification of~~ the ~~relevant urinary markers was based primarily upon~~ the ~~prevalence~~ of ~~the in~~-~~vivo metabolites instead~~ of the ~~metabolites ranking that was based upon % peak area abundance ratio. Moreover~~, ~~genetic makeup~~, ~~physiological conditions (age~~, ~~gender visit this website link and ethnicity)~~, ~~environmental influences (diet) and pathological factors (liver diseases~~, ~~diabetes~~, ~~and obesity~~) ~~would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity~~ and ~~matrix effects bias for each metabolite~~.~~<br>Victim B also brought "something resembling~~ a ~~drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50)~~ of 4F-~~MDMB-BINACA is 5~~.~~69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2,~~ in ~~vitro half-life (t1/2) is 10~~.~~27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur~~	+	Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017<br><br>The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human<br><br><br>Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). cannabinoidsrc4f-adb.com [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com site] Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br><br>§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death<br><br>The % peak area abundance ratio of metabolites detected in the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stabilit<br><br>4. Drugs <br>The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in humans. Drug discrimination is a well-known animal model of the subjective effects of drugs and correlates well with abuse liability (Young 2009; Horton et al. 2013). Assessment of abuse liability is based on several factors, including chemical structure, pharmacological mechanism of action, and finally, subjective and reinforcing behavioral effects (FDA, 2010; Swedberg, 2013).<br>Michael B Gat<br><br><br>These synthetic cannabinoids act cannabinoidsrc4f-adb.com site directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patient.<br>Data availabili

← Older revision		Revision as of 07:05, 26 May 2026
Line 1:		Line 1:
−	~~Some mice showed abnormal behaviors (catalepsy~~, ~~loss of traction~~, ~~convulsion) right after the administration~~ of the ~~tested substances. The locomotor activity~~ of ~~the mice was measured 30 min~~ and ~~2 hrs after the~~ last ~~substance administration~~. ~~We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in~~ the ~~nucleus accumbens core region~~. ~~In histopathological analysis, neural cells of the animals treated~~ with ~~the high dose~~ (~~5 mg/kg~~) ~~of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes~~ in the ~~core shell of nucleus accumbens, suggesting neurotoxicity~~.~~<br>Table of Conten<br><br><br>This makes JWH~~-~~210 powder one of the most powerful compounds~~ in ~~its class~~, ~~often used in incense blends and research settings~~. ~~Our commitment~~ to ~~quality and customer satisfaction makes us~~ the ~~best place for jwh 210 buy~~-~~whether you need it for research~~, ~~incense blends, or other legal applications. For qualified professionals, investing in high~~-~~quality, verified material ensures accuracy, safety,~~ and ~~regulatory compliance. Prioritize vendors providing full analytical validation~~, ~~transparent documentation, and compliance~~ with ~~international controls. Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alon~~<br><br><br>~~The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC.~~ In summary, ~~these 5F~~-~~MDMB~~-~~PINACA~~, ~~MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA~~, and ~~AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion~~. ~~Much of the in vivo~~ [https://cannabinoidsrc4f-adb.com/ ~~5CL ADBA powder~~] ~~testing~~ of the ~~synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid~~-~~like effects or like the present study, focused on their abuse liability~~. ~~There is indication~~ that ~~at least some~~ of ~~the first~~-~~generation synthetic cannabinoids act at receptors other than cannabinoid CB1~~ and ~~CB2~~ (~~Wiley~~ et al., ~~2016)~~, and ~~a compound from the present study~~, ~~5F-MDMB-PINACA, was found to activate midbrain dopamine neurons~~, ~~but not serotonin neurons (Asaoka~~ et al., ~~2016~~<br><br>~~<br>To evaluate whether~~ the ~~changes~~ of ~~coordinative functions by CNS damages were due~~ to ~~test substances~~, ~~rota~~-~~rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea)~~. ~~The test apparatus~~ for ~~the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051~~, ~~Benwick Electronics~~, ~~Benwick~~, ~~UK) when experimental animals moved in the chamber. In both tests~~, a ~~group~~ of mice ~~were treated with negative control (vehicle, 1 mg/kg~~, i.~~p.)~~, positive control (methamphetamine, 1 mg/kg, i.p.), ~~or one~~ of the ~~three doses~~ of test ~~substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day~~<br><br><br>~~Tremors were observed~~ in ~~mice 30 minutes following 1 mg/kg AMB~~-~~FUBINACA in the present study. Pretreatment times~~ and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (~~Gatch~~ et al., 2014)~~, whereas the potency of a recent set was 0~~.~~09±0.03~~ mg/kg (~~Gatch et al.~~, ~~2018~~), ~~and the potency of the current set is 0.05±0.01 mg/kg. Short~~-~~onset~~, ~~short~~-~~acting compounds have a greater abuse liability~~, and ~~long~~-~~acting compounds pose problems of long~~-~~acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids~~ tested ~~using the 8~~-~~h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems~~ to ~~be a trend of newer synthetic cannabinoids being more potent than earlier compound~~<br><br>~~The chemical structures of~~ the ~~recent synthetic cannabinoids are unlike that~~ of ~~Δ9-THC, but are largely based on~~ the ~~structure of older synthetic cannabinoids that are known~~ to ~~have substantial abuse liability (Fig~~. ~~1<br><br>~~In ~~case of cannabis or Δ9-tetrahydrocannabinol~~, ~~there are many previous studies regarding with their dependence potential~~ and ~~neurotoxicity~~ (~~Cororan~~, ~~et al~~., ~~1974; Harris, et al~~.~~, 1974; Leite and Culini, 1974; Hutcheson, et al~~.~~, 1998~~<br><br><br>~~Taken together these data further confirmed the structure elucidation~~ of ~~B16. The precursor ion m/z 276~~ (~~B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite~~ (~~B22~~)~~, indicated N-dealkylation of B22~~. ~~The precursor ion m/z 348~~ and ~~product ion detected at m~~/~~z 217 (B2~~) ~~identified~~ was ~~2 Da less than~~ the ~~4F-MDMB-BINACA ester hydrolysis metabolite~~ (~~B22~~)~~, indicating oxidative defluorination (loss~~ of ~~fluorine with addition~~ of ~~hydroxy 5CL ADBA powder group<br><br>Figure 1~~. ~~<br>Each training session lasted a maximum~~ of ~~10 min,~~ and the ~~rats could earn up~~ to ~~20 food pellets~~. ~~Thirty minutes prior to~~ the ~~training sessions, rats received an injection~~ of ~~either vehicle or Δ9~~-~~THC and were subsequently placed in~~ the ~~behavior-testing chambers~~, ~~where food~~ (~~45-mg food pellets; Bio-Serve~~, ~~Frenchtown~~, NJ) ~~was available as a reinforcer for every ten responses~~ (~~FR10~~) ~~on a designated injection appropriate lever. A houselight was centered over~~ the ~~hopper close to the ceiling and was illuminated only when the levers were active~~. ~~Each dose range included doses~~ that ~~were without effect to those producing at least 50~~% ~~depression compared~~ to ~~vehicle control~~. ~~Twenty-four male Sprague-Dawley rats were obtained~~ from ~~Envigo~~ (~~Houston, TX~~). ~~Male ND4 Swiss–Webster mice were obtained from Envigo~~ (~~Houston, TX~~) ~~at approximately 8 weeks~~ of ~~age~~ and ~~maintained~~ in ~~the University of North Texas Health Science Center~~ (~~UNTHSC~~) ~~animal facility for two weeks prior to testin~~	+	Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>The % peak area abundance ratio of metabolites detected in the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stability. This indicated that the phase I metabolism of 4F-MDMB-BINACA are unlikely to be affected significantly by polydrug intake. Oxidative defluorination with subsequent butanoic acid formation (B17) metabolite, the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in-vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA and MDMB-4en-PINACA [39, 40]. Similar to the in-vivo findings, 4F-MDMB-BINACA ester hydrolysis (B22) was the major metabolite for both HepG2 and HLM models, consistent with the known hydrolytic activity of CES reported<br><br><br>In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to [https://cannabinoidsrc4f-adb.com/ visit this website link] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>Key Features and Specifications to Evaluate <br>In case of cannabis or Δ9-tetrahydrocannabinol, there are many visit this website link previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration.<br>How to Choose Powder JWH-210 <br>This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research.<br>Is JWH-210 Legal? <br>A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive control group (methamphetamine, 5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance<br><br>Figure 1. <br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>After the incubation, mixture was centrifuged (18,000 x g, 20 °C) for 5 min and 0.5 μL of the supernatant was directly injected to the chromatographic system. In the next step, ammonium formate as salting agent was added to the mixture and incubated in a thermomixer (20 °C, 1200 rpm) for 15 min. After vortex-mixing, the mixture was allowed to stand visit this website link at room temperature for 5 min. MS/MS experiments were performed in MRM (multiple reaction monitoring) mode with an isolation window of 0.4 m/z. The MS measurement was performed in positive ion mode (except for some acidic compounds such as barbiturates<br><br>Fig. 2. <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender visit this website link and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur

← Older revision		Revision as of 07:10, 25 May 2026
Line 1:		Line 1:
−	Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br>~~Fig. 2. <br>Our findings revealed~~ that ~~both victims consumed large amounts~~ of ~~alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L~~, ~~respectively). Forensic autopsy of both victims was performed four days after~~ the ~~time~~ of ~~death following the Recommendation No.R~~ (~~99)3 of the Council of Europe on medico-legal autopsies~~. ~~Elegans demonstrated the ability to form all~~ of ~~the in~~-~~vivo metabolites and has the~~ potential ~~to be used as a complementary model to predict~~ and ~~characterize human metabolites~~, ~~as well as identifying possible drug toxicities for emerging SCBs~~. ~~Thus~~, ~~identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio~~. ~~Moreover~~, ~~genetic makeup, physiological conditions (age, gender Cannabinoidsrc 4f Adb blog post~~ and ~~ethnicity)~~, ~~environmental influences (diet) and pathological factors (liver diseases~~, ~~diabetes~~, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>~~Data concerning~~ the ~~combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation~~ of ~~possible overdose cases difficult~~ . The ~~threshold SCRA concentration for fatal overdose can be estimated ng~~/~~mL level~~ (~~0.37–4.1 ng/mL according to the reported cases~~) ~~in cases in~~ which ~~1.5–2.5 g/L of ethanol is present in~~ the ~~blood. The victims were brothers who were both found deceased after consuming~~ 4F-MDMB-BINACA and ~~ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to~~ the ~~public. Monitoring metabolism of synthetic cannabinoid~~ 4F-MDMB-BINACA ~~via high-resolution mass spectrometry assessed in cultured hepatoma cell line~~, ~~fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies~~ with ~~human participants or animals performed by any~~ of ~~the author~~<br><br><br>~~LC-QTOF-MS represents~~ a ~~significant advancement in the field~~ of ~~drug detection, offering higher sensitivity, specificity~~, and ~~a broader spectrum of detectable substances~~. ~~Despite all negative results in~~ the ~~point-of-care test for recreational drugs~~, ~~the liquid chromatography-quadrupole time-~~of-~~flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of~~ the ~~e-cigarette contained ADB~~-~~BUTINACA~~, ~~a synthetic cannabinoid. We report a 27~~-~~year~~-~~old man who was admitted to the emergency room because of sudden Cannabinoidsrc 4f Adb blog post headache~~, ~~nausea~~, ~~vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly availabl<br><br><br>JWH-210 Chemical Powder offers~~ a ~~reliable solution~~ for ~~laboratories seeking~~ a ~~compound that meets stringent requirements~~. ~~Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects,~~ the ~~compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification~~ to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the ~~detection~~ and ~~identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test~~ was ~~initially performed on~~ the ~~urine of the patient~~. ~~He confirmed drinking 750 ml energy drink~~ without ~~any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms~~. ~~He usually smokes a pack of cigarettes a day and sometimes smokes e~~-~~cigarettes. Combined with non~~-~~specific~~, ~~transient symptoms, clinical recognition of SCRA intoxication is challenging~~ .~~<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the Cannabinoidsrc 4f Adb [https://cannabinoidsrc4f-adb.com/ Cannabinoidsrc 4f Adb blog post] post presence and elution profiles~~ of ~~nicotine~~ and ~~ADB-BUTINACA~~ in the ~~analysed vape liquid sample. LC-QTOF-MS Chromatograms~~ of ~~Nicotine~~ (~~Top~~) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom	+	Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity.<br>Table of Conten<br><br><br>This makes JWH-210 powder one of the most powerful compounds in its class, often used in incense blends and research settings. Our commitment to quality and customer satisfaction makes us the best place for jwh 210 buy-whether you need it for research, incense blends, or other legal applications. For qualified professionals, investing in high-quality, verified material ensures accuracy, safety, and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation, and compliance with international controls. Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alon<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo [https://cannabinoidsrc4f-adb.com/ 5CL ADBA powder] testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>To evaluate whether the changes of coordinative functions by CNS damages were due to test substances, rota-rod test was performed using Rota-rod apparatus (Daejong, Seoul, Korea). The test apparatus for the locomotor activity test was designed to measure locomotor activity automatically using UV system (AM 1051, Benwick Electronics, Benwick, UK) when experimental animals moved in the chamber. In both tests, a group of mice were treated with negative control (vehicle, 1 mg/kg, i.p.), positive control (methamphetamine, 1 mg/kg, i.p.), or one of the three doses of test substances (0.1, 1, 5 mg/kg, i.p.) once every other day for 10 day<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br>The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1<br><br>In case of cannabis or Δ9-tetrahydrocannabinol, there are many previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998<br><br><br>Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy 5CL ADBA powder group<br><br>Figure 1. <br>Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin